Arno Therapeutics is actively seeking to in-license, acquire or co-develop drugs for cancer.

Arno's Mission is to develop cancer therapies to improve patient's lives. Our business model is focused on guiding molecules through pre-clinical and all stages of clinical development. We offer extensive pharmaceutical experience and expertise in an agile, small organization. Our focus is to build each product's strategy by designing a strategic plan to efficiently generate the required safety and efficacy data, speed-to-market and return on investment. Arno management has the experience of developing breakthrough products in all stages of development from pre-clinical through late stage clinical trials.

If you are interested in working with Arno Therapeutics, please contact us directly at: info@arnothera.com.